Andreas Wicki

University of Zurich

Switzerland

Research Interests

Explore related searches

Professors in Switzerland Professors in Immunology Immunology professors in Switzerland

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Collaborators (7)

Matthias Schwenkglenks

University of Zurich

SWITZERLAND

View details

Sabine Rohrmann

University of Zurich

SWITZERLAND

View details

Michael Schmid

Head of Bioinformatics and LabIT

University Hospital of Zurich

SWITZERLAND

View details

Martin D. Berger

SWITZERLAND

View details

Louisa Hempel

Sigmund Freud University

AUSTRIA

View details

Jean-Luc Bulliard

Head of sector Epidemiology and Data Science & Scientific Director of Neuchâtel-Jura Cancer Registry

Centre for Primary Care and Public Health (Unisanté), University of Lausanne

SWITZERLAND

View details

Tarun Mehra

University Hospital of Zurich

SWITZERLAND

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Andreas Wicki

Research Interests

Explore related searches

Contact this professor

Articles (10)

Comparative inpatient care of cancer vs. non-cancer patients in Switzerland during the national COVID-19 lockdown: a nationwide interrupted time series analysis.

Integrating Formalin-Fixed, Paraffin-Embedded–Derived Whole-Genome Sequencing into Routine Molecular Pathology

Estimating the indirect costs associated with adenocarcinoma or squamous cell carcinoma of the oesophagus in Switzerland: evidence from a cross-sectional survey

Precision Oncology Program (POP), an observational study using real-world data and imaging mass cytometry to explore decision support for the Molecular Tumor Board: study protocol

Precision Oncology Guided by Genomic Profiling in Breast Cancer: Real-World Data from a Molecular Tumor Board

Feasibility of multiomics tumor profiling for guiding treatment of melanoma

Standardization of Suspension and Imaging Mass Cytometry Single-Cell Readouts for Clinical Decision Making.

Effect of the COVID-19 pandemic and lockdown on cancer stage distribution and time to treatment initiation using cancer registry data of the Swiss cantons of Zurich and Zug from 2018 to 2021

A medical AI chatbot purpose-built to support general practitioners in Switzerland

Neoadjuvant Treatment With Regorafenib and Capecitabine Combined With Radiotherapy in Locally Advanced Rectal Cancer: A Multicenter Phase Ib Trial (RECAP)-SAKK 41/16.

Collaborators (7)

Matthias Schwenkglenks

Sabine Rohrmann

Michael Schmid

Martin D. Berger

Louisa Hempel

Jean-Luc Bulliard

Tarun Mehra

Make your next move.